Valuation: Olympus Corporation

Market Cap 1,948B 12.27B 11.18B 10.3B 9.37B 17.58B 1,137B 18.47B 125B 49.83B 621B 46.05B 45.08B P/E 2027 *
18.2x
P/E 2028 * 16x
Enterprise Value 2,029B 12.78B 11.64B 10.73B 9.76B 18.31B 1,184B 19.24B 131B 51.89B 646B 47.96B 46.94B EV / Sales 2027 *
1.88x
EV / Sales 2028 * 1.8x
Free-Float
94.58%
Yield 2027 *
1.67%
Yield 2028 * 1.75%
1 day-0.84%
1 week+2.37%
Current month+5.22%
1 month+8.78%
3 months-14.00%
6 months-2.24%
Current year-7.63%
1 week 1,774
Extreme 1774
1,860.5
1 month 1,677.5
Extreme 1677.5
1,860.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 64 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Director/Board Member 59 2021-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%+2.37%-7.94%-16.24% 12.29B
-2.79%-4.38%+16.90%+42.75% 255B
-3.16%-5.43%-0.82%+4.42% 160B
-2.01%-10.04%-27.74%+28.17% 141B
-2.35%-5.32%-56.54%-22.92% 62.31B
-1.95%-4.95%+21.12%+51.59% 59.73B
-1.96%-1.92%+3.84%-14.15% 53.49B
-2.83%-2.06%+17.45%+49.48% 49.43B
-3.51%-4.30%+16.33%+68.80% 44.87B
+1.26%-11.71%-1.58%+48.97% 42.57B
Average -2.18%-2.65%-1.90%+24.09% 88B
Weighted average by Cap. -2.50%-3.51%-0.41%+27.13%

Financials

2027 *2028 *
Net sales 1,081B 6.81B 6.2B 5.71B 5.2B 9.75B 630B 10.25B 69.53B 27.63B 344B 25.54B 25B 1,119B 7.05B 6.42B 5.92B 5.38B 10.1B 653B 10.61B 72.01B 28.62B 357B 26.45B 25.89B
Net income 107B 676M 616M 567M 516M 968M 62.58B 1.02B 6.9B 2.74B 34.18B 2.54B 2.48B 122B 771M 702M 647M 588M 1.1B 71.38B 1.16B 7.87B 3.13B 38.99B 2.89B 2.83B
Net Debt 80.62B 508M 463M 426M 388M 727M 47.03B 765M 5.19B 2.06B 25.69B 1.91B 1.87B 61.03B 384M 350M 323M 293M 551M 35.6B 579M 3.93B 1.56B 19.45B 1.44B 1.41B
Projected Income Statement - Annual - Olympus Corporation
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-11-20 ¥1,833.00 -0.84% 4,438,700
26-11-19 ¥1,848.50 +2.81% 2,909,400
26-11-18 ¥1,798.00 +0.33% 2,883,700
26-11-17 ¥1,792.00 0.00% 2,836,300
26-11-16 ¥1,792.00 +0.90% 4,288,700
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Olympus Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,833.00JPY
Average target price
2,084.62JPY
Spread / Average Target
+13.73%
  1. Stock Market
  2. Stocks
  3. 7733 Stock